VIDEO ACCESS
- MAYO STAFF: Access this pre-recorded session on the Video Exchange website.
- MAYO CLINIC CARE NETWORK: Click here to return to the video.
RELEASE: January 22, 2020
EXPIRATION: December 31, 2021 (Credit is not available after this expiration date.)
LEARNING OBJECTIVES
- Discuss the role of atrial fibrillation as a predictor of outcome in valvular heart disease.
- Review the indications for aortic and mitral valve repair or replacement.
Accreditation Statement

In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s)
AMA
The Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
INSTRUCTIONS
- Click the Start button below.
- Participate in the quiz. Participants must pass by a minimum of 80%, 1 re-take is allowed. Quizzes have between 2-5 questions.
- Complete the evaluation.
TRANSCRIPT
This credit will appear on your Transcript for permanent record. To access your transcript, visit My Account, My Activities, RSS Transcript.
DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.
Listed below are individuals with control of the content of this program who have disclosed…
Relevant financial relationship(s) with industry:
Committee Members:
Panithaya Chareonthaitawee, M.D., Ph.D. – Consultant: Bioclinica, Medtrace, GE Healthcare; Other: Up-To-Date (Royalties)
Jae K. Oh, M.D. – Consultant: Medtronic for Valve Projects; Other – Up-To-Date, Pericardial Disease Section Editor
Patricia A. Pellikka, M.D. – Consultant: Bracco; Grant/Research Support: Lantheus, GE Healthcare; Honoraria: UpToDate
No relevant financial relationship(s) with industry:
Thomas Ladas, M.D., Ph.D.
Committee Members:
Thomas C. Gerber, M.D., Ph.D., Garvan C. Kane, M.D., Ph.D.; Barry Karon, M.D., Rekha Mankad, M.D., Sunil V. Mankad, M.D., Sorin V. Pislaru, M.D., Monica L. Schroeder
References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
Committee Member:
None
QUESTIONS?
MAYO STAFF: Contact Monica Schroeder, Department Coordinator, at ph. 507-266-2643.
MAYO CLINIC CARE NETWORK MEMBERS: Contact cme@mayo.edu

Facebook
X
LinkedIn
Forward